Learn More
This article presents the results of the immunological profile of CD4+ T cells and Th17 cells and production of interleukin-17 (IL-17) in two groups of patients receiving treatment natalizumab and(More)
We assessed effectiveness, safety and tolerability of betahistine in neurologic outpatients with dizziness. We examined 200 patients treated with 48 mg/d of betahistine during 60 days. Common state(More)